Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;2(1):15-26.
doi: 10.1007/s13167-011-0066-1. Epub 2011 Mar 5.

Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases

Hana Rosolova  1 , Barbora Nussbaumerova
Affiliations

Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases

Hana Rosolova et al. EPMA J. 2011 Mar.

Abstract

Cardiovascular atherosclerotic diseases represent the main cause of death in the developed and developing populations. Although major progress has been made in the management of the classical modifiable cardiovascular risk factors, unhealthy lifestyle conduces to an increasing prevalence of overweight, obesity, metabolic disorders, type 2 diabetes mellitus, premature atherosclerosis and cardiovascular diseases. That is why cardio-metabolic risk prediction should be superior in the primary prevention of atherosclerosis and cardiovascular diseases. Up-to-date primary preventive strategies according to the European Guidelines, especially the high risk strategy approach, are being implemented. Individual cardiovascular and better cardio-metabolic risk assessment represents the basic approach in the individualized primary prevention of cardiovascular diseases and type 2 diabetes mellitus. Cardio-metabolic biomarkers, especially high sensitivity C-reactive protein, albuminuria, N-terminal pro-brain natriuretic peptide, and imaging procedures (carotid intima-media thickness measured by ultrasound) could improve the prediction of cardiovascular diseases and type 2 diabetes beyond that using traditional risk factors.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Mortality of ischemic heart disease in European and other countries [2]. CARK - 5 central Asian republics including Kazakhstan, CIS - 12 countries of the “Commonwealth of Independent States”, EU – European Union, Eur-A – Western European countries, Eur – B+C – Middle and Eastern European countries
Fig. 2
Fig. 2
Prevalence of type 2 diabetes mellitus in European and other countries [2], CARK - 5 central Asian republics including Kazakhstan, CIS - 12 countries of the “Commonwealth of Independent States”, Eur – B+C – Middle and Eastern European countries
Fig. 3
Fig. 3
SCORE - European Low Risk Chart [3]
See this image and copyright information in PMC

References

    1. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: WHO, Dec 2009. Assessed at: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_re...
    1. http://data.euro.who.int/hfadb
    1. Graham I, Atar D, Borch-Johnsen K, et al. Task Force Members: European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil. 2007;14(Suppl.2):E1–40. - PubMed
    1. Laakso M. Hyperglycaemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48:937–42. - PubMed
    1. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet. 2004;364:937–52. - PubMed